Literature DB >> 17974726

Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction.

Patrick Jean-Philippe1, Abigail Freedman, Mary Wu Chang, Sharon P Steinberg, Anne A Gershon, Philip S LaRussa, William Borkowsky.   

Abstract

In March 1995, the US Food and Drug Administration approved a live attenuated varicella vaccine for use in healthy children 12 months to 12 years old. We report here an 18-month-old girl with cell-mediated immunodeficiency who developed a severe vaccine-associated rash and clinical evidence of vaccine-associated pneumonia 1 month after inadvertent receipt of varicella vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974726     DOI: 10.1542/peds.2004-1681

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  A Toddler With Rash, Encephalopathy, and Hemolytic Anemia.

Authors:  Christiana Smith; Cullen Dutmer; D Scott Schmid; Megan K Dishop; William J Bellini; Erwin W Gelfand; Edwin J Asturias
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-28       Impact factor: 3.164

2.  Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.

Authors:  Pamela P W Lee; Koon-Wing Chan; Tong-Xin Chen; Li-Ping Jiang; Xiao-Chuan Wang; Hua-Song Zeng; Xiang-Yuan Chen; Woei-Kang Liew; Jing Chen; Kit-Man Chu; Lee-Lee Chan; Lynette Shek; Anselm C W Lee; Hsin-Hui Yu; Qiang Li; Chen-Guang Xu; Geraldine Sultan-Ugdoracion; Zarina Abdul Latiff; Amir Hamzah Abdul Latiff; Orathai Jirapongsananuruk; Marco H K Ho; Tsz-Leung Lee; Xi-Qiang Yang; Yu-Lung Lau
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

3.  Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

Authors:  Barbara A Pahud; Carol A Glaser; Cornelia L Dekker; Ann M Arvin; D Scott Schmid
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

5.  Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray.

Authors:  D K Bayer; C A Martinez; H S Sorte; L R Forbes; G J Demmler-Harrison; I C Hanson; N M Pearson; L M Noroski; S R Zaki; W J Bellini; M S Leduc; Y Yang; C M Eng; A Patel; O K Rodningen; D M Muzny; R A Gibbs; I M Campbell; C A Shaw; M W Baker; V Zhang; J R Lupski; J S Orange; F O Seeborg; A Stray-Pedersen
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

6.  Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation.

Authors:  Preeti Bhalla; Graeme N Forrest; Michael Gershon; Yan Zhou; Jason Chen; Philip LaRussa; Sharon Steinberg; Anne A Gershon
Journal:  Clin Infect Dis       Date:  2014-12-01       Impact factor: 9.079

7.  Perspectives on vaccines against varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 8.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

10.  Fatal varicella due to the vaccine-strain varicella-zoster virus.

Authors:  Jessica Leung; Subhadra Siegel; James F Jones; Cynthia Schulte; Debra Blog; D Scott Schmid; Stephanie R Bialek; Mona Marin
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.